Cargando…
Individualization of treatment in non-small cell lung cancer
Two recently reported randomized studies discussed below are paving the way for personalized treatment approaches for patients with non-small cell lung cancer (NSCLC). Both studies show that accurate subclassification of NSCLC will become necessary to prescribe chemotherapy doublets and epidermal gr...
Autor principal: | van Zandwijk, Nico |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920715/ https://www.ncbi.nlm.nih.gov/pubmed/20948757 http://dx.doi.org/10.3410/M1-24 |
Ejemplares similares
-
Progress in individualized treatment for EGFR-mutated advanced non-small cell lung cancer
por: INOUE, Akira
Publicado: (2020) -
Histology Matters: Individualizing Treatment in Non-Small Cell Lung Cancer
por: Neal, Joel W.
Publicado: (2010) -
Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer
por: Scagliotti, G V, et al.
Publicado: (2006) -
Aptamers in Non-Small Cell Lung Cancer Treatment
por: Wieleba, Irena, et al.
Publicado: (2020) -
Sintilimab for the treatment of non-small cell lung cancer
por: Zhang, Lin, et al.
Publicado: (2022)